Prism Center
@PrismCenter
Followers
192
Following
58
Media
0
Statuses
50
National Precision Oncology Center A unique partnership between @GustaveRoussy @centralesupelec @UnivParisSaclay @GroupeUnicancer @Inserm
Villejuif
Joined June 2020
đ Lancement du Prix Gustave Roussy pour rĂ©compenser lâinnovation scientifique en #cancĂ©rologie đ Ă lâoccasion du 150e anniversaire de la naissance de son fondateur et Ă lâaube des 100 ans de lâInstitut qui porte aujourdâhui son nom, @GustaveRoussy est fier dâannoncer le
0
10
19
Advances in #PrecisionOncology are moving the field towards biology-based #CancerCare: ESMO is supporting the change with a series of tailored resources for medical oncologists. Read @FAndreMD interview in the #ESMODailyReporter đ https://t.co/IHkELh1FIA
0
11
37
We introduce Sopa, a technology-invariant, memory-efficient pipeline with a unified visualizer for all image-based spatial omics. Another great result of the strong collaboration between @GustaveRoussy and @centralesupelec
https://t.co/VKIgxh5naL
nature.com
Nature Communications - The complexity of spatial omics data presents analytical challenges and demands substantial computing resources. Here, the authors introduce Sopa, a technology-invariant,...
0
1
9
The kick-off Meeting of the @PrismCenter IHU-A will be on Thursday May 2nd. Itâs an opportunity to organise a nice seminar around Precision Medicine w @VivekSubbiah & @NickyMcGranahan as speakers. you are welcome to join us (+ there is a cocktail at the end đ„đ§đčđ„€đ§đ”âïž !)
0
9
38
đ° Cancer : la rĂ©volution des nouveaux traitements, notamment Ă @GustaveRoussy. Un article Ă dĂ©couvrir dans @lobs đ https://t.co/Xt0uoEXQWw
0
22
100
MĂȘme Ă faible dose, lâalcool peut augmenter le risque de dĂ©velopper plusieurs cancers, chez les âïž comme chez les âïž. La campagne de santĂ© publique, #LeDĂ©fiDeJanvier, incite Ă ne pas boire dâalcool du 01 au 31/01, une aide utile pour mieux contrĂŽler sa consommation annuelle.đȘ
0
12
16
đą Nous n'avons jamais autant guĂ©ri du cancer qu'aujourd'hui. Pourtant, les belles avancĂ©es rĂ©alisĂ©es vers la guĂ©rison de cette maladie sont encore trop peu connues. L'occasion de (re)dĂ©couvrir cette âš histoire vraie âš en vidĂ©o —
0
12
34
Congratulations @ypradat đWe are so glad to have you onboard. Looking forward to what you'll achieve with @Elsa2Bernard đ
I am thrilled to announce that I will be supported by a postdoctoral fellowship from @FondationARC for the next 3y to investigate the molecular features of treatment-related myeloid leukemias. Work under the supervision of @Elsa2Bernard at @GustaveRoussy and part of @PrismCenter.
0
0
6
Welcome, Elsa ! We are thrilled to have you onboard đ€©
Le Dr Elsa Bernard a rejoint @GustaveRoussy en septembre dernier, en tant que cheffe de groupe de l'Ă©quipe Oncologie clinique computationnelle au sein de l'@Inserm U981 et de l'IHU @PrismCenter. Bienvenue Ă l'institut @Elsa2Bernard ! đ€
0
1
7
1st award @myESMO : I Ray-Coquard on rare gyne cancers. How to improve outcome: precise dg (referral), quality of network (infrastructure & scient collab), guidelines adh, inclusion of all stakeholders, database, biomarker driven approvals. @PrismCenter cited ! #ESMO2023
1
7
41
Chercheurs, mĂ©decins et mathĂ©maticiens unissent leurs compĂ©tences pour rĂ©aliser des "jumeaux numĂ©riques" capables de simuler le comportement dâune tumeur. Par @lestavelt â€”ïž https://t.co/T2ZFDJR39O
0
1
1
.@PrismCenter selected to receive 30-40 M euros to build a Precision Oncology Center. Vision: to classify pts based on biology. Scientific strategy: bottom-up approach to model cancer biology in each pt (fig 2) for early cancer or relapse detection, & tt optimisation (fig 3).
12
37
147
Dans le cadre du plan #France2030 du @gouvernementFR, @GustaveRoussy est fier dâannoncer la labellisation du centre national de mĂ©decine de prĂ©cision #Prism qui devient officiellement aujourdâhui l'un des 5 Instituts Hospitalo-Universitaire dotĂ©s Ă hauteur de 30/40 millions. 1/3
1
14
54
đŁ Donât miss out the second edition of Transatlantic Exchanges w/ @DanaFarber @GustaveRoussy on May 5th in Paris đđ
Interested in #AI and #DataScience in #Oncology? đą Register for the 2nd Transatlantic Exchanges đ 5 May đ Paris + #Virtual đ virtual reg https://t.co/WIwzZ9xkzd đ in person reg https://t.co/WolS0MPOrO
@DrChoueiri @VanAllenLab @MariaVakalopou1 @valerie_paradis @AI4Pathology
0
4
8
« Owkin lance PortrAIt, un consortium visant Ă faire de la France un leader mondial dans lâutilisation de lâIA pour diagnostiquer et traiter les maladies » @GustaveRoussy @Owkin đ° Lire le #CommuniquĂ©DePresse | https://t.co/FTi2tlxsuI
0
6
15
After 2 y hard work, this very large public funding is the kick-off of đ«đ· Onco-Biocluster (PSCC). Mission: grow start-up, pharma, bio/medtech, ie private sector, in 100000 m2 close to @GustaveRoussy . As always it starts with friendshipđ (đ@jsoriamd ).
#santeđ§Ź@Elisabeth_Borne annonce le 1er laurĂ©at de l'AMI âBioclusterâ #France2030 : Paris Saclay Cancer Clusterđ đŻDĂ©velopper un Ă©cosystĂšme d'innovation Ă grande Ă©chelle en rassemblant les acteurs clĂ©s de l'innovation oncologique Ă Villejuif. âDĂ©tails https://t.co/NqcJhO8AeJ
3
7
61
WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint https://t.co/u3Zkh7TJLP. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.
0
6
19
SAFIR 02 BREAST RCT shows that using genomic analysis to target therapies can improve outcomes in MBC
Clinical briefing: Precision medicine improves outcomes in metastatic breast cancer
0
0
0
Two first-in-class rapid, affordable #AI-based diagnostic solutions designed to improve patient outcomes with #breastcancer and #colorectalcancer have been approved for use in Europe. https://t.co/QWfbW0edNP
1
12
30
Pandore study of neoadjuvant pembrolizumab in MIBC reported in @CD_AACR :TFH and IgG directed against urothelium invasive Escherichia coli dictated clinical responses to pembrolizumab. A @GustaveRoussy study with the @GETUG_Unicancer and Zitvogel's lab
1
13
23